Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2007-4-10
pubmed:abstractText
A series of phenyl acetic acid based quinolines was prepared as LXR modulators. An SAR study in which the C-3 and C-8 positions of the quinoline core were varied led to the identification of two potent LXR agonists 23 and 27. Both compounds displayed good binding affinity for LXRbeta and LXRalpha, and increased expression of ABCA1 in THP-1 cells. These two compounds also had desirable pharmacokinetic profiles in mice and displayed in vivo efficacy in a 12-week Apo E knockout mouse lesion model.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E, http://linkedlifedata.com/resource/pubmed/chemical/Carboxylic Acids, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Indicators and Reagents, http://linkedlifedata.com/resource/pubmed/chemical/Orphan Nuclear Receptors, http://linkedlifedata.com/resource/pubmed/chemical/Phenylacetates, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Solvents, http://linkedlifedata.com/resource/pubmed/chemical/liver X receptor, http://linkedlifedata.com/resource/pubmed/chemical/phenylacetic acid
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0968-0896
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3321-33
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17391964-Animals, pubmed-meshheading:17391964-Apolipoproteins E, pubmed-meshheading:17391964-Atherosclerosis, pubmed-meshheading:17391964-CHO Cells, pubmed-meshheading:17391964-Carboxylic Acids, pubmed-meshheading:17391964-Chromatography, High Pressure Liquid, pubmed-meshheading:17391964-Cricetinae, pubmed-meshheading:17391964-Cricetulus, pubmed-meshheading:17391964-DNA-Binding Proteins, pubmed-meshheading:17391964-Humans, pubmed-meshheading:17391964-Indicators and Reagents, pubmed-meshheading:17391964-Magnetic Resonance Spectroscopy, pubmed-meshheading:17391964-Male, pubmed-meshheading:17391964-Mice, pubmed-meshheading:17391964-Mice, Inbred C57BL, pubmed-meshheading:17391964-Mice, Knockout, pubmed-meshheading:17391964-Orphan Nuclear Receptors, pubmed-meshheading:17391964-Phenylacetates, pubmed-meshheading:17391964-Quinolines, pubmed-meshheading:17391964-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:17391964-Recombinant Proteins, pubmed-meshheading:17391964-Solvents, pubmed-meshheading:17391964-Spectrometry, Mass, Electrospray Ionization, pubmed-meshheading:17391964-Structure-Activity Relationship, pubmed-meshheading:17391964-Transcriptional Activation
pubmed:year
2007
pubmed:articleTitle
Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.
pubmed:affiliation
Chemical and Screening Sciences, Wyeth Pharmaceuticals, 500 Arcola Road, Collegeville, PA 19426, USA. hub@wyeth.com
pubmed:publicationType
Journal Article